TiSe(2)-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer

BACKGROUND: Pancreatic cancer remains among the most prevalent and aggressive forms of cancer. While immunotherapeutic treatment strategies have shown some promise in affected patients, the benefits of these interventions have been limited by insufficient tumor infiltration by activated T cells. RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Libin, Xue, Wang, Cao, Jing, Zhang, Shengmin, Zeng, Yiqing, Ma, Ling, Qian, Xuechen, Wen, Qing, Hong, Yurong, Shi, Zhan, Xu, Youfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571469/
https://www.ncbi.nlm.nih.gov/pubmed/36243711
http://dx.doi.org/10.1186/s12951-022-01659-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571469/
https://www.ncbi.nlm.nih.gov/pubmed/36243711
http://dx.doi.org/10.1186/s12951-022-01659-4

Ejemplares similares